$SCYX
SCYNEXIS INC

2020 Q2 Form 10-Q Financial Statement

#000156459020038629 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q4 2019 Q2
Revenue $0.00 $0.00 $57.00K
YoY Change -100.0% -100.0% -10.94%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.357M $3.150M $2.779M
YoY Change 20.8% 46.51% 30.9%
% of Gross Profit
Research & Development $8.469M $10.96M $8.474M
YoY Change -0.06% 63.58% 51.35%
% of Gross Profit
Depreciation & Amortization $20.00K $20.00K $30.00K
YoY Change -33.33% -33.33%
% of Gross Profit
Operating Expenses $11.83M $14.11M $11.25M
YoY Change 5.09% 59.44% 45.73%
Operating Profit -$11.83M -$11.20M
YoY Change 5.63%
Interest Expense $319.0K -$890.0K $209.0K
YoY Change 52.63% -122.25% -47.36%
% of Operating Profit
Other Income/Expense, Net $2.301M $540.0K $2.793M
YoY Change -17.62% -87.44% -190.13%
Pretax Income -$9.525M -$14.46M -$8.403M
YoY Change 13.35% 201.88% -21.91%
Income Tax -$3.144M $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.381M -$14.46M -$8.403M
YoY Change -24.06% -845.36% -21.88%
Net Earnings / Revenue -14742.11%
Basic Earnings Per Share -$0.64
Diluted Earnings Per Share -$0.64 -$2.191M -$1.576M
COMMON SHARES
Basic Shares Outstanding 10.01M
Diluted Shares Outstanding 10.01M

Balance Sheet

Concept 2020 Q2 2019 Q4 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.60M $48.40M $35.20M
YoY Change 6.82% 9.5% -36.23%
Cash & Equivalents $34.00M $41.92M $19.15M
Short-Term Investments $3.600M $6.500M $16.10M
Other Short-Term Assets $863.0K $674.0K $55.00K
YoY Change 1469.09% 1148.15% -95.77%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $40.57M $52.40M $36.14M
YoY Change 12.24% 1.82% -36.04%
LONG-TERM ASSETS
Property, Plant & Equipment $354.0K $405.0K $460.0K
YoY Change -23.04% -21.51% 11.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $812.0K $812.0K $812.0K
YoY Change 0.0% 0.0% 41.71%
Total Long-Term Assets $4.700M $4.751M $4.931M
YoY Change -4.68% 178.32% 209.54%
TOTAL ASSETS
Total Short-Term Assets $40.57M $52.40M $36.14M
Total Long-Term Assets $4.700M $4.751M $4.931M
Total Assets $45.27M $57.15M $41.07M
YoY Change 10.21% 7.49% -29.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.853M $7.177M $3.806M
YoY Change 27.51% 96.47% 46.38%
Accrued Expenses $2.387M $3.801M $3.414M
YoY Change -30.08% 80.74% 113.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.316M $11.01M $7.248M
YoY Change 0.94% 87.41% -44.9%
LONG-TERM LIABILITIES
Long-Term Debt $18.30M $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $13.40M $21.70M $8.800M
YoY Change 52.27% 2070.0% -2.22%
Total Long-Term Liabilities $31.70M $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.316M $11.01M $7.248M
Total Long-Term Liabilities $31.70M $0.00 $0.00
Total Liabilities $38.93M $44.26M $7.248M
YoY Change 437.17% 101.68% -76.99%
SHAREHOLDERS EQUITY
Retained Earnings -$284.8M -$271.4M
YoY Change 24.67%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.333M $12.90M $10.40M
YoY Change
Total Liabilities & Shareholders Equity $45.27M $57.15M $41.10M
YoY Change 10.14% 7.49% -29.26%

Cashflow Statement

Concept 2020 Q2 2019 Q4 2019 Q2
OPERATING ACTIVITIES
Net Income -$6.381M -$14.46M -$8.403M
YoY Change -24.06% -845.36% -21.88%
Depreciation, Depletion And Amortization $20.00K $20.00K $30.00K
YoY Change -33.33% -33.33%
Cash From Operating Activities -$8.850M -$13.46M -$7.760M
YoY Change 14.05% 122.48% -1.77%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $10.67M $10.04M $10.02M
YoY Change 6.49% 1376.47% -183.99%
Cash From Investing Activities $10.66M $10.04M $10.02M
YoY Change 6.39% 1573.33% -181.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.96M 33.72M 3.930M
YoY Change 204.33% 4012.2% -1808.7%
NET CHANGE
Cash From Operating Activities -8.850M -13.46M -7.760M
Cash From Investing Activities 10.66M 10.04M 10.02M
Cash From Financing Activities 11.96M 33.72M 3.930M
Net Change In Cash 13.77M 30.30M 6.190M
YoY Change 122.46% -754.43% -130.25%
FREE CASH FLOW
Cash From Operating Activities -$8.850M -$13.46M -$7.760M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$8.850M -$13.46M -$7.760M
YoY Change 14.05% 125.84% 3.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M2D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M13D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y5M1D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y7M6D
CY2020Q2 scyx Warrant Liability Current
WarrantLiabilityCurrent
33000
CY2019Q4 scyx Warrant Liability Current
WarrantLiabilityCurrent
0
CY2019Q4 us-gaap Deferred Costs
DeferredCosts
70000
CY2020Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
273000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3988000
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
273000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3094000
CY2020Q2 us-gaap Deferred Costs
DeferredCosts
167000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
812000
CY2020Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
3594000
CY2019Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
6494000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2952000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3191000
CY2020Q2 us-gaap Assets
Assets
45267000
CY2019Q4 us-gaap Assets
Assets
57153000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4853000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7177000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2387000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3801000
CY2019Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
18396000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
36000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7316000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11014000
CY2020Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
10034000
CY2019Q4 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
11522000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3330000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3326000
CY2020Q2 us-gaap Liabilities
Liabilities
38934000
CY2019Q4 us-gaap Liabilities
Liabilities
44258000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9741372
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9741372
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
405000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
40567000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
52402000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
812000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
354000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3357000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18335000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18158000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2779000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5021000
us-gaap Operating Expenses
OperatingExpenses
24301000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11826000
CY2020Q2 us-gaap Interest Expense
InterestExpense
319000
us-gaap Interest Income Other
InterestIncomeOther
183000
us-gaap Interest Income Other
InterestIncomeOther
513000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8469000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8474000
CY2020Q2 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
18254000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10478927
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10478927
CY2020Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
10000
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
291134000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-284811000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
6333000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45267000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5966000
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11196000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
11253000
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-806000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-806000
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
321000
CY2019Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
373000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
599000
CY2020Q2 us-gaap Interest Income Other
InterestIncomeOther
36000
CY2019Q2 us-gaap Interest Income Other
InterestIncomeOther
233000
CY2019Q2 us-gaap Interest Expense
InterestExpense
209000
us-gaap Operating Income Loss
OperatingIncomeLoss
-24301000
CY2019Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
602000
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3560000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8403000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
6455000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2301000
us-gaap Net Income Loss
NetIncomeLoss
-13383000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
284313000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-271428000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
12895000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57153000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
11826000
us-gaap Operating Expenses
OperatingExpenses
23179000
us-gaap Operating Income Loss
OperatingIncomeLoss
-23058000
CY2019Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-231000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1045000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
573000
us-gaap Interest Expense
InterestExpense
529000
us-gaap Interest Expense
InterestExpense
574000
CY2020Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
60000
CY2019Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
405000
CY2020Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
602000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8329000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4473000
CY2020Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
693000
CY2019Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1324000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1393000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2101000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2793000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7774000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8253000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9525000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8403000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16527000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31311000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3144000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3144000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6381000
us-gaap Net Income Loss
NetIncomeLoss
-13383000
us-gaap Net Income Loss
NetIncomeLoss
-31311000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
10000
CY2019Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2049000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
16000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
462000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1253000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
89000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
599000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
573000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8329000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4473000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15973000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12111000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5353000
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.64
CY2019Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.58
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.35
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-6.10
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10009614
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7899000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7711000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5327766
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9877094
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5130855
us-gaap Profit Loss
ProfitLoss
-13383000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42193000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11767000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34294000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19478000
us-gaap Interest Paid Net
InterestPaidNet
420000
us-gaap Interest Paid Net
InterestPaidNet
411000
us-gaap Profit Loss
ProfitLoss
-31311000
us-gaap Depreciation
Depreciation
54000
us-gaap Depreciation
Depreciation
59000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
821000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1393000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2101000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
938000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
23000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
173000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
540000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
scyx Noncash Operating Lease Expense For Right Of Use Asset
NoncashOperatingLeaseExpenseForRightOfUseAsset
97000
scyx Noncash Operating Lease Expense For Right Of Use Asset
NoncashOperatingLeaseExpenseForRightOfUseAsset
81000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-806000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1045000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3365000
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
0
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
4000
scyx Noncash Consideration Associated With Common Stock Purchase Agreement
NoncashConsiderationAssociatedWithCommonStockPurchaseAgreement
602000
us-gaap Stock Issued1
StockIssued1
2784000
us-gaap Stock Issued1
StockIssued1
2984000
scyx Noncash Consideration Associated With Common Stock Purchase Agreement
NoncashConsiderationAssociatedWithCommonStockPurchaseAgreement
0
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1069000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-6504000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3833000
scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
106000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1488000
scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
0
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0
scyx Common Stock Issued For Commitment Shares
CommonStockIssuedForCommitmentShares
602000
scyx Common Stock Issued For Commitment Shares
CommonStockIssuedForCommitmentShares
0
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-284800000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34000000.0
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-121000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22913000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14259000
CY2020Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
3600000
CY2018Q3 scyx Shelf Registration Maximum Equity Offering Price
ShelfRegistrationMaximumEquityOfferingPrice
175000000.0
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
17142000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
43202000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
14235000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
26585000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2018Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1319807
CY2018Q3 scyx Warrants Expiration Date
WarrantsExpirationDate
2019-03-14
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2903000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16617000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2751000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6761000
scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
123000
scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
203000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
18000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
21000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
73000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
10000000
CY2018Q3 scyx Aggregate Amount Receivable Upon Exercise Of Warrants
AggregateAmountReceivableUponExerciseOfWarrants
28600000
CY2018Q3 scyx Shelf Registration Maximum Equity Offering Price
ShelfRegistrationMaximumEquityOfferingPrice
175000000.0
CY2020Q2 scyx Shelf Registration Maximum Equity Offering Price
ShelfRegistrationMaximumEquityOfferingPrice
124800000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9332077
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3025609
CY2020Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
62000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
19000
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
863000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
674000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2952000
CY2020Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3594000
CY2020Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0
CY2020Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
0
CY2020Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3594000
CY2019Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
6494000
CY2019Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
15000
CY2019Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
14000
CY2019Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
6495000
CY2020Q2 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
1254000
CY2019Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
3043000
CY2020Q2 us-gaap Prepaid Insurance
PrepaidInsurance
773000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
252000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3988000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
284000
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2020Q2 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
654000
CY2019Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
1296000
CY2020Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
759000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1798000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
974000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
707000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2387000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3801000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
CY2018Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has the option to renew for two consecutive five-year periods from the end of the first term and the Company is not reasonably certain that the option to renew the Lease will be exercised. Under the Lease, the Company furnished a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which was reduced by fifty-five thousand dollars on the first anniversary of the commencement date.  The security deposit will continue to be reduced by fifty-five thousand dollars every two years on the commencement date anniversary for eight years.
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
us-gaap Operating Lease Cost
OperatingLeaseCost
332000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
6000
us-gaap Variable Lease Cost
VariableLeaseCost
27000
CY2020Q2 us-gaap Lease Cost
LeaseCost
172000
us-gaap Lease Cost
LeaseCost
359000
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
56000
us-gaap Operating Lease Payments
OperatingLeasePayments
223000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-73000
scyx Stock Issued During Period Value Commitment Shares
StockIssuedDuringPeriodValueCommitmentShares
602000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
517000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
527000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
715000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
730000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3533000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6306000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3373000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3330000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3373000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2933000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3094000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10478927
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10478927
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9741372
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9741372
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6381000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
410000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2463000
CY2020Q2 scyx Stock Issued During Period Value Commitment Shares
StockIssuedDuringPeriodValueCommitmentShares
602000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
6333000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
12895000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
821000
scyx Stock Issued During Period Value Employee Stock Purchase Plan And Stock Option Plans
StockIssuedDuringPeriodValueEmployeeStockPurchasePlanAndStockOptionPlans
18000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2669000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
6333000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
11330000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8403000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
446000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4046000
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-1000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
10402000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
31225000
us-gaap Net Income Loss
NetIncomeLoss
-31311000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
938000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
21000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2019Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6556000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-11000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
10402000
CY2020Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9548935
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8143816
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3600000
CY2019Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2000000.0
CY2020Q2 scyx Fair Value Of Liabilities
FairValueOfLiabilities
10100000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
526070
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.55
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
60000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
278537
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.59
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
166
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
22756
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
20.66
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
781685
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.01
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
21000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
385059
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
35.22
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
19000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
781685
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
23.01
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
21000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
800000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
CY2020Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
411000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
446000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
821000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
938000

Files In Submission

Name View Source Status
0001564590-20-038629-index-headers.html Edgar Link pending
0001564590-20-038629-index.html Edgar Link pending
0001564590-20-038629.txt Edgar Link pending
0001564590-20-038629-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-10q_20200630.htm Edgar Link pending
scyx-10q_20200630_htm.xml Edgar Link completed
scyx-20200630.xsd Edgar Link pending
scyx-20200630_cal.xml Edgar Link unprocessable
scyx-20200630_def.xml Edgar Link unprocessable
scyx-20200630_lab.xml Edgar Link unprocessable
scyx-20200630_pre.xml Edgar Link unprocessable
scyx-ex101_240.htm Edgar Link pending
scyx-ex102_239.htm Edgar Link pending
scyx-ex103_238.htm Edgar Link pending
scyx-ex104_236.htm Edgar Link pending
scyx-ex105_237.htm Edgar Link pending
scyx-ex311_6.htm Edgar Link pending
scyx-ex312_7.htm Edgar Link pending
scyx-ex321_8.htm Edgar Link pending
Show.js Edgar Link pending